Rubitecan
CAS No. 91421-42-0
Rubitecan ( RFS 2000;9-Nitrocamptothecin )
Catalog No. M20618 CAS No. 91421-42-0
Rubitecan is a DNA topoisomerase I inhibitor.?It inhibits DNA topoisomerase I and increases the fraction of supercoiled DNA in a cell-free assay in a concentration-dependent manner.Rubitecan is a semisynthetic agent related to camptothecin with potent antitumor and antiviral properties.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
10MG | 63 | In Stock |
|
50MG | 151 | In Stock |
|
100MG | 227 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRubitecan
-
NoteResearch use only not for human use.
-
Brief DescriptionRubitecan is a DNA topoisomerase I inhibitor.?It inhibits DNA topoisomerase I and increases the fraction of supercoiled DNA in a cell-free assay in a concentration-dependent manner.Rubitecan is a semisynthetic agent related to camptothecin with potent antitumor and antiviral properties.
-
DescriptionRubitecan is a DNA topoisomerase I inhibitor.?It inhibits DNA topoisomerase I and increases the fraction of supercoiled DNA in a cell-free assay in a concentration-dependent manner.Rubitecan is a semisynthetic agent related to camptothecin with potent antitumor and antiviral properties.
-
SynonymsRFS 2000;9-Nitrocamptothecin
-
PathwayCell Cycle/DNA Damage
-
TargetTopoisomerase
-
Recptortopoisomerase I
-
Research AreaCancer
-
IndicationTumors
Chemical Information
-
CAS Number91421-42-0
-
Formula Weight393.35
-
Molecular FormulaC20H15N3O6
-
Purity>98% (HPLC)
-
SolubilityDMSO:125 mg/mL (317.78 mM)
-
SMILESCC[C@@]1(O)C(=O)OCc2c1cc1-c3nc4cccc([N+]([O-])=O)c4cc3Cn1c2=O
-
Chemical Name(S)-4-ethyl-4-hydroxy-10-nitro-1H-pyrano[3'4':67]indolizino[12-b]quinoline-314(4H12H)-dione
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Sands H Mishra A Stoeckler J D et al. Preclinical activity of an i.v. formulation of rubitecan in IDD-P against human solid tumor xenografts[J]. Anti-Cancer Drugs 2002 13(9):965-975.
molnova catalog
related products
-
Voreloxin
A first-in-class anticancer quinolone derivative that intercalates DNA and inhibits Topoisomerase II.
-
9-Methoxycamptotheci...
9-Methoxycamptothecin (MCPT) has antitumour activities through topoisomerase inhibition.
-
Prulifloxacin
Prulifloxacin is a broad-spectrum fluoroquinolone antibiotic. It Inhibits bacterial DNA synthesis by inhibiting the activity of bacterial DNA topoisomerase II and IV.